Results 111 to 120 of about 2,034,426 (313)
Recent advances in aortic valve replacement for aortic stenosis [version 1; referees: 2 approved]
Aortic valve replacement is no longer an operation that is approached solely through a median sternotomy. Recent advances in the fields of transcatheter valves have expanded the proportion of patients eligible for intervention.
Ahmed Al-Adhami, Nawwar Al-Attar
doaj +1 more source
ABSTRACT The prognostic nutritional index (PNI) and geriatric nutritional risk index (GNRI) are simple markers that reflect immune and nutritional status. This retrospective study evaluated their prognostic significance in 276 patients with advanced hepatocellular carcinoma (HCC) who received first‐line lenvatinib. PNI and GNRI were calculated based on
Cheng‐Wei Kuo +9 more
wiley +1 more source
Transcatheter Intervention for Heart Failure: Excitement, Progress, and Trepidation. [PDF]
Généreux P, Testani JM.
europepmc +1 more source
Sleep‐disordered breathing in valvular heart disease: A Modifiable comorbidity
Abstract Sleep‐disordered breathing (SDB) is highly prevalent among patients with valvular heart disease (VHD) and is independently associated with adverse clinical outcomes. The two major phenotypes—obstructive sleep apnea (OSA) and central sleep apnea (CSA)—exhibit distinct distributions across VHD subtypes. CSA predominates in severe aortic stenosis,
Wu Juan +6 more
wiley +1 more source
ABSTRACT Background and Objectives While in vitro fertilization with intracytoplasmic sperm injection (IVF‐ICSI) bypasses abnormalities in sperm concentration, motility, and morphology, it still has a significant failure rate. We report our experience on the effect of varicocele embolization (VE) on couples with varicocele related primary male factor ...
Anthony Verstandig, Adam Farkas
wiley +1 more source
LVAD‐associated aortic regurgitation impairs circulatory support, with limited surgical and off‐label options. In a multicenter registry (n = 30), the AR‐dedicated JenaValve Trilogy TAVR eliminated AR, achieving 96.7% (29/30) technical success and 93.3% (28/30) device success (VARC‐3), with 3.3% (1/30) 30‐day mortality.
Hristian Hinkov +13 more
wiley +1 more source
The Heart in the Transcatheter Intervention Era: Where Are We? [PDF]
Tagliari AP, Taramasso M.
europepmc +1 more source
Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention
ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou +5 more
wiley +1 more source
Frailty and Five‐Year Mortality After TAVR in Patients Aged 75 Years and Older
In patients aged 75 years and older undergoing transcatheter aortic valve replacement, frailty assessed by the Clinical Frailty Scale was the most robust geriatric factor independently associated with five‐year mortality. This study highlights the specific prognostic value of frailty beyond short‐term outcomes.
Jérémie Huet +4 more
wiley +1 more source
K-clip™, a novel transcatheter treatment in patients with severely tricuspid regurgitation
Patients who suffer from severe tricuspid regurgitation (TR) and who are at high surgical risk have no standard care therapy. Therefore, minimally invasive and safer methods are sought.
Jiandong Ding +3 more
doaj +1 more source

